NASDAQ:VNDA 延时15分钟

成交量

Mihael Hristos Polymeropoulos: Mihael Hristos Polymeropoulos is the founder of Vanda Pharmaceuticals, Inc., founded in 2002. Titles held at Vanda Pharmaceuticals, Inc. include Chairman, President & Chief Executive Officer since 2021. Dr. Polymeropoulos is also the founder of Integrated Molecular Analysis of Genome Expression.. Former jobs include VP & Head-Pharmacogenetics Department at Novartis AG from 1998 to 2003 and Chief-Gene Mapping Section at National Human Genome Research Institute from 1992 to 1998. Education includes undergraduate studies at the University of Patras.

Mihael Hristos Polymeropoulos: Mihael Hristos Polymeropoulos is the founder of Vanda Pharmaceuticals, Inc., founded in 2002. Titles held at Vanda Pharmaceuticals, Inc. include Chairman, President & Chief Executive Officer since 2021. Dr. Polymeropoulos is also the founder of Integrated Molecular Analysis of Genome Expression.. Former jobs include VP & Head-Pharmacogenetics Department at Novartis AG from 1998 to 2003 and Chief-Gene Mapping Section at National Human Genome Research Institute from 1992 to 1998. Education includes undergraduate studies at the University of Patras.

Richard W. Dugan: Richard W. Dugan is Lead Independent Director at Vanda Pharmaceuticals, Inc. since 2022. Formerly, Mr. Dugan was Director at Middlebrook Pharmaceuticals, Inc. from 2003 to 2010, Director at Critical Therapeutics, Inc. from 2004 to 2008, Director at Antisoma, Inc., and Senior Partner at Ernst & Young LLP from 2001 to 2002. Mr. Dugan completed undergraduate studies at The Pennsylvania State University.; 旧服务已下线，请迁移至 http://api.fanyi.baidu.com

Phaedra S. Chrousos: Phaedra S. Chrousos was the founder of Daily Secret, Inc. (2010) where the title held was Chief Operating Officer. Ms. Chrousos was the founder of Vitals Consumer Services LLC (2009) where the title held was Vice President. Ms. Chrousos was the founder of Healthleap, Inc. (2009) where the title held was President. Current jobs include Independent Director at Vanda Pharmaceuticals, Inc. since 2019, Director at Beeck Center of Georgetown University, Chief Strategy Officer at Libra Group Ltd. since 2018, Strategic Advisor at Hangar, and Board Member at Dcode since 2016. Education history includes undergraduate degree from Georgetown University (2002), graduate studies at London School of Economics & Political Science, and MBA from Columbia Business School (2008).

Anne Sempowski Ward: Anne Sempowski Ward was the founder of The Forward Group, established in 2008, where the title held was Chief Executive Officer from 2010 to 2012. Current jobs include Chairman at CURiO Brands LLC since 2024, Independent Director at Vanda Pharmaceuticals, Inc. since 2019, and Independent Director at SPS Commerce, Inc. since 2020. Former jobs include Chief Executive Officer at The Thymes LLC from 2012 to 2016, Associate Marketing Director at Procter & Gamble Co. from 1994 to 2006, Independent Director at Spectrum Brands Holdings, Inc. from 2020 to 2021, Assistant Vice President at The Coca-Cola Co. from 2006 to 2007, and President, COO-Ebony, Jet & Fashion Fair Cosmetic at Johnson Publishing Co. LLC from 2007 to 2010. Education history includes undergraduate and graduate degrees from Duke University conferred in 1993 and 1994, respectively, and an MBA degree from The Fuqua School of Business conferred in 2004.

Stephen Ray Mitchell: Stephen Ray Mitchell is an Independent Director at Vanda Pharmaceuticals, Inc. since 2020. Dr. Mitchell is a Director at Gottlieb Memorial Hospital. Dr. Mitchell is Dean-Medical Education at Georgetown University School of Medicine since 1992 and 2002 respectively. Formerly, Dr. Mitchell was a Director at Loyola University Health System. From 2013 to 2019, Dr. Mitchell was a Member of the Liaison Committee On Medical Education. Dr. Mitchell completed undergraduate and doctorate degrees at The University of North Carolina at Chapel Hill and earned an MBA from McDonough School of Business.

Tage Honor: Tage Honor is the founder of Aestus Partners LLC, founded in 2004, and holds the title of President. Current jobs include Independent Director at Vanda Pharmaceuticals, Inc. since 2023 and Head-Pharmaceutical Development at Avicenna Biosciences, Inc. since 2020. Former job includes Chairman at Dep-Xplora ApS from 2013 to 2019. Education includes graduate and doctorate degrees from the University of Copenhagen.

Charles C. Duncan: Charles C. Duncan is currently an Independent Director at Vanda Pharmaceuticals, Inc. since 2026. Formerly, Dr. Duncan was a Biotechnology Analyst at Cantor Fitzgerald & Co. from 2018 to 2025. Served as Senior Research Analyst at Piper Sandler & Co. (Broker) from 2014 to 2018. Worked as Managing Director & Senior Analyst at Citizens JMP Securities LLC in 2012. Held analyst roles at Prudential Securities, Chatfield Dean & Co., Inc., and Tucker Anthony Cleary Gull. Was Principal at Dresdner Kleinwort Wasserstein Group, Inc. Education includes undergraduate studies at the University of Wisconsin and a doctorate from The University of Colorado.

Vanda Pharmaceuticals, Inc.